| Item Type | Name |
|
Concept
|
Anticoagulants
|
|
Academic Article
|
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.
|
|
Academic Article
|
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
|
|
Academic Article
|
The economics of venous thromboembolism prophylaxis: a primer for clinicians.
|
|
Academic Article
|
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
|
|
Academic Article
|
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
|
|
Academic Article
|
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
|
|
Academic Article
|
Oral rivaroxaban for symptomatic venous thromboembolism.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
|
|
Academic Article
|
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
|
|
Academic Article
|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
|
|
Academic Article
|
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
|
|
Academic Article
|
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial.
|
|
Academic Article
|
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
|
|
Academic Article
|
Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients.
|
|
Academic Article
|
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
|
|
Academic Article
|
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials.
|
|
Academic Article
|
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Anticoagulant therapy for venous thromboembolism.
|
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
|
Academic Article
|
Preventing systemic embolism in patients with abnormal ventricular function.
|
|
Academic Article
|
Cost effectiveness of diagnosis of deep vein thrombosis in symptomatic patients.
|
|
Academic Article
|
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
|
|
Academic Article
|
Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
|
|
Academic Article
|
Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
|
|
Academic Article
|
Low molecular weight heparin, heparin, and warfarin.
|
|
Academic Article
|
Oral anticoagulant therapy.
|
|
Academic Article
|
Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice.
|
|
Academic Article
|
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.
|
|
Academic Article
|
Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
|
|
Academic Article
|
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.
|
|
Academic Article
|
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
|
|
Academic Article
|
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.
|
|
Academic Article
|
Idraparinux versus standard therapy for venous thromboembolic disease.
|
|
Academic Article
|
Extended prophylaxis of venous thromboembolism with idraparinux.
|
|
Academic Article
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
|
|
Academic Article
|
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials.
|
|
Academic Article
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
|
|
Academic Article
|
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups.
|
|
Academic Article
|
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
|
|
Academic Article
|
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
|
|
Academic Article
|
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial.
|
|
Academic Article
|
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
|
|
Academic Article
|
Edoxaban for Cancer-Associated Venous Thromboembolism.
|
|
Academic Article
|
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent.
|
|
Academic Article
|
Clinical implications of incidental venous thromboembolism in cancer patients.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
|
|
Academic Article
|
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
|
|
Academic Article
|
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.
|
|
Academic Article
|
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
|
Academic Article
|
Aging and heparin-related bleeding.
|
|
Academic Article
|
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
|
|
Academic Article
|
Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
|
|
Academic Article
|
Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.
|
|
Academic Article
|
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.
|
|
Academic Article
|
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
|
|
Academic Article
|
Duration of warfarin in pulmonary embolism.
|
|
Academic Article
|
Prevention of central venous catheter-associated thrombosis: a meta-analysis.
|
|
Academic Article
|
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
|
|
Academic Article
|
Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.
|
|
Academic Article
|
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
|
|
Academic Article
|
Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
|
|
Academic Article
|
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
|
|
Academic Article
|
Hemorrhagic complications of long-term anticoagulant therapy.
|
|
Academic Article
|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
|
|
Academic Article
|
Oral apixaban for the treatment of acute venous thromboembolism.
|
|
Academic Article
|
Long-term anticoagulant therapy prevents recurrent venous thromboembolism.
|
|
Academic Article
|
Oral anticoagulants: new and improved.
|
|
Academic Article
|
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
|
|
Academic Article
|
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
|
|
Academic Article
|
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
|
|
Academic Article
|
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
|
|
Academic Article
|
Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement.
|
|
Academic Article
|
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.
|
|
Academic Article
|
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
|
|
Academic Article
|
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
|
|
Academic Article
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
|
Academic Article
|
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
|
|
Academic Article
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
|
Academic Article
|
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
|
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
|
|
Academic Article
|
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study.
|
|
Academic Article
|
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
|
|
Academic Article
|
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists.
|
|
Academic Article
|
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
|
|
Academic Article
|
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial.
|
|
Academic Article
|
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
|
|
Academic Article
|
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
|
|
Academic Article
|
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
|
|
Academic Article
|
Diagnosis and management of pulmonary thromboembolism.
|
|
Academic Article
|
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism.
|
|
Academic Article
|
Prophylaxis of venous thromboembolic disease following hip and knee surgery.
|
|
Academic Article
|
Prophylaxis of venous thromboembolism. An overview.
|
|
Academic Article
|
Risk of haemorrhage associated with long term anticoagulant therapy.
|
|
Academic Article
|
Hemorrhagic complications of anticoagulant treatment.
|
|
Academic Article
|
Long-term oral anticoagulant therapy for coronary artery disease.
|
|
Academic Article
|
Duration of anticoagulant treatment for venous thrombosis.
|
|
Grant
|
THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENT
|
|
Academic Article
|
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients.
|
|
Academic Article
|
Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.
|
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism. Reply.
|
|
Academic Article
|
Milvexian for the Prevention of Venous Thromboembolism.
|
|
Academic Article
|
Abelacimab for Prevention of Venous Thromboembolism.
|
|
Academic Article
|
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
|
|
Academic Article
|
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban.
|
|
Academic Article
|
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
|
|
Academic Article
|
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
|
|
Academic Article
|
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score.
|
|
Academic Article
|
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
|
|
Academic Article
|
Redefining clinical venous thromboembolism phenotypes: a?novel approach using latent class analysis.
|
|
Academic Article
|
Anticoagulant Therapy for Mechanical Heart Valves - Unmet Need Persists.
|